Cite Filings / CMPX / 0001140361-22-019763

Feed Companies Filings Check

Sign in

DEFA14A

Proxy Materials

Compass Therapeutics, Inc. Filed 2022-05-18 Acc 0001140361-22-019763

Documents 1

DEFA14A Proxy Materials , ny20004267x1_defa14a.htm

Around this filing

2023-04-27 DEFA14A Proxy Materials
2022-05-24 4 CHIEF EXECUTIVE OFFICER bought 18,355 shares at $2.72 ($49,926)
2022-05-18 DEFA14A Proxy Materials
2022-05-17 4 CHIEF EXECUTIVE OFFICER bought 20,215 shares at $2.47 ($49,931)
2022-05-13 4 Director bought 192,516 shares at an average $2.18 ($420,482)
2022-05-13 4 Director bought 192,516 shares at an average $2.18 ($420,482)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading ny20004267x1_defa14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…